论文部分内容阅读
CD3AK细胞在体外对体外癌细胞系细胞杀伤活性最强，对自体癌细胞杀伤活性与TIL细胞接近，且均显著大于LAK细胞．CD3AK细胞IL－2治疗癌症患者30例中，CR＋PR14例，有效率为46％．Kernofsky的生活质量标准评分治疗后有显著提高（P＜0．01）．血浆IL－2活性治疗后有明显提高（P＜0．05）．T4／T6治疗后有所提高．
CD3AK cells had the strongest cytotoxic activity against cancer cell lines in vitro, and the autologous cancer cell killing activity was similar to that of TIL cells, and both were significantly larger than LAK cells. CD3AK cells IL-2 treatment of cancer in 30 cases, CR + PR14 cases, the effective rate was 46%. Kernofsky’s quality of life criteria scores improved significantly after treatment (P<0.01). Plasma IL-2 activity was significantly improved after treatment (P<0.05). Increased after T4/T6 treatment.